In line with these findings, negative relationships between elevated miR-155 levels and the deficiency in cell regulators, such as PU.1, TP53INP1, p21 (CDKN1A), and cyclin D1 (CCND1), have also been reported in CLL [11]. Here, CDKN1A is linked to B-cell chronic lymphocytic leukemia.